BioPharma Credit (LON:BPCR) Reaches New 52-Week High - Should You Buy?

BioPharma Credit (LON:BPCR - Get Free Report)'s stock price hit a new 52-week high on Tuesday . The stock traded as high as GBX 0.91 ($0.01) and last traded at GBX 0.91 ($0.01), with a volume of 394539 shares changing hands. The stock had previously closed at GBX 0.91 ($0.01).

BioPharma Credit Stock Performance

The firm has a 50 day moving average of GBX 0.87 and a two-hundred day moving average of GBX 0.87. The stock has a market cap of £1.08 billion, a P/E ratio of 10.34 and a beta of 0.22.

BioPharma Credit Cuts Dividend

The firm also recently announced a dividend, which was paid on Wednesday, May 7th. Investors of record on Thursday, April 3rd were paid a dividend of $0.02 per share. The ex-dividend date was Thursday, April 3rd. This represents a yield of 1.99%. BioPharma Credit's payout ratio is 7,957.15%.

About BioPharma Credit

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.